NHI Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 1.83%, SMA50 7.97%, SMA200 14.85%). The stock’s 14-day RSI is 59.7 (neutral), while the ATR of 1.88 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -3.88% below its high and over 32.25% above its low. Average 10-day trading volume of 255.45 thousand shares is below the 3-month average of 555.38 thousand, indicating normal recent market interest.

National Health Investors, Inc. last paid a dividend of 3.68 per share, this equals a trailing yield of roughly 5.15%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $198.39. This means the shares are trading below this model’s fair value.

National Health Investors, Inc. has 49.11 million shares outstanding. The public float is 47.94 million shares, elevated short interest at 3.12% of float. This equals 1.50 million shares. The short ratio is 3.38 days. Institutional investors hold 77.67% of the float. Insiders own 2.42%. ADAMS W ANDREW holds 759.78 thousand shares, ADAMS ROBERT G has 180.55 thousand shares and Mendelsohn D. Eric has 133.32 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

National Health Investors, Inc. generated EPS of $3.17 over the past year. Five-year average earnings growth is -3.17%. Wall Street analysts project EPS growth of 4.09% annually over the next five years. The latest quarter delivered EPS of $1.19. The next quarter is forecast at $0.79. Next year's EPS is expected at -$8.69. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 5 Buy ratings, 6 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $94.00 to $79.00. The high target offers 32.62% upside. The low target suggests 11.46% downside. The mean target is $84.73. This offers 19.54% upside. National Health Investors, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 10, 2026, missed forecasts by 41.16%. The prior quarter beat by -11.06%. Over the last six quarters, Apple has recorded several small beats. These include 1.77% in May 05, 2025.

National Health Investors, Inc. (NYSE:NHI) closed at $70.88 USD, losing -$1.03 (-1.43%) from the previous close of $71.91. The stock is currently within 5% of its 52-week low $67.94 and $91.38. With a market capitalization of about $3.44 billion, National Health Investors, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.56). Key stats such as the average daily volume over the past year has been around 565.81 thousand shares, volume is running light vs its 52-week average. Headquartered in Murfreesboro, TN, National Health Investors, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO D. Eric Mendelsohn, the company employs approximately 32 people and listed since October 09, 1991. Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets.

National Health Investors, Inc. trades at a P/E ratio of 20.5, slightly below the S&P 500 average, with a price-to-sales ratio of 7.95 and a price-to-book ratio of 2.19 suggesting the stock is closer to book value. The P/FCF stands at 14.63, also above market averages.

National Health Investors, Inc. (NYSE:NHI) shares are flat 4.36% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows National Health Investors, Inc. trading at a premium to the broader market with a P/E of 20.5. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $73.11, suggesting 3.15% upside. Our AI forecast model points to short-term strength (0.73% over two weeks), a medium-term fall (-40.11% over three months), and a longer-term gain (15.86% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that National Health Investors, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.73%, with price expected at $71.40 by September 17, 2026, within a range of $69.95 to $72.86 3-Month Outlook: Projected fall of -40.11%, reaching $42.45 by December 02, 2026, with a range of $37.87 to $44.97. 1-Year Outlook: Projected gain of 15.86%, with price at $82.12 by September 03, 2027, within a range of $79.71 to $84.25.